Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8196752 | 0.99 | XDH (0.76) | XDHGDA | |
| SCHEMBL17274775 | 0.95 | XDH (0.76) | XDHGDA | |
| SCHEMBL9806979 | 0.89 | XDH (0.71) | XDHGDA | |
| SCHEMBL5935074 | 0.89 | XDH (0.78) | XDHGDA | |
| SCHEMBL4384744 | 0.87 | XDH (1.00) | XDHGDA | |
| SCHEMBL27959660 | 0.87 | XDH (0.77) | XDHGDA | |
| SCHEMBL8535457 | 0.87 | XDH (1.00) | XDHGDA | |
| Hydrochloric Acid SCHEMBL258899 | 0.86 | XDH (0.97) | XDHGDA | |
| SCHEMBL249649 | 0.85 | XDH (1.00) | XDHGDA | |
| Hydrochloric Acid SCHEMBL30610398 | 0.85 | XDH (0.95) | XDHGDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2989112-B1 | MODIFIED G-QUADRUPLEX NANOPARTICLES | UNIV NANYANG TECH (SG) | 2021-09-22 | — | — | EP | disclosed |
| US-20160310519-A1 | MODIFIED G-QUADRUPLEX NANOPARTICLES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-10-27 | — | — | US | disclosed |
| EP-2989112-A1 | MODIFIED G-QUADRUPLEX NANOPARTICLES | Nanyang Technological University (SG) | 2016-03-02 | — | — | EP | disclosed |
| WO-2014175836-A1 | MODIFIED G-QUADRUPLEX NANOPARTICLES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310519-A1 | MODIFIED G-QUADRUPLEX NANOPARTICLES | NCL, G3BP1, NPM1 | XDH 3185/4885GDA 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.